Physiologically based pharmacokinetic modeling to understand the observed drug–drug interaction of LY2623091 with CYP3A inhibitors itraconazole and diltiazem
Cardioprotective Effects of Combined Therapy with Hyperbaric Oxygen and Diltiazem Pretreatment on Myocardial Ischemia-Reperfusion Injury in Rats
Tags: Cardizem®, hypertension, non-DHP calcium channel blocker, Tiazac®, vasodilator
BASi Method Number SAP.1694
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
